Skip to main content
Watch Insiders
EDITHealthcare

Editas Medicine Inc (EDIT) Insider Trading

In the last 90 days, 3 Editas Medicine Inc (EDIT) insiders reported no open-market purchases and 4 sales totaling $20,841. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 3, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 3, 2026Amy ParisonSVP, Chief Financial OfficerSale453$3.04$1,376
Sep 3, 2026Linda BurklyEVP, CHIEF SCIENTIFIC OFFICERSale709$3.04$2,153
Sep 3, 2026Gilmore Neil O'NeillCEOSale5,124$3.04$15,563
Aug 3, 2026Amy ParisonSVP, Chief Financial OfficerSale678$2.58$1,749
Jul 28, 2026Linda BurklyEVP, CHIEF SCIENTIFIC OFFICERSale4,928$2.67$13,158
Jun 3, 2026Amy ParisonSVP, Chief Financial OfficerSale464$2.70$1,253
Jun 3, 2026Gilmore Neil O'NeillCEOSale15,380$2.70$41,543
Jun 3, 2026Linda BurklyEVP, CHIEF SCIENTIFIC OFFICERSale731$2.70$1,975

Common questions

EDIT insider trading FAQ

Are EDIT insiders buying or selling?
Over the last 90 days, EDIT insiders were net sellers, reporting $0.00 of open-market purchases and $20,841 of sales.
When was the last EDIT insider purchase?
No open-market insider purchase of Editas Medicine Inc stock was reported in the last 90 days.
Where does EDIT insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Editas Medicine Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.